| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 感染控制解决方案(元) | 756,129,198.28 | 424,255,211.17 | 1,184,210,933.52 | 627,046,391.40 |
| 呼吸治疗解决方案(元) | 3,371,243,855.78 | 2,308,325,460.68 | 2,239,261,579.21 | 1,099,262,950.01 |
| 急救(元) | 163,497,222.05 | 80,034,541.48 | 151,336,620.06 | 63,896,111.78 |
| 家用类电子检测及体外诊断(元) | 1,673,717,540.18 | 1,067,929,709.16 | 1,520,862,946.41 | 809,979,993.76 |
| 康复及临床器械(元) | 1,227,903,924.54 | 708,067,995.76 | 1,408,460,887.05 | 649,078,793.18 |
| 糖尿病护理解决方案(元) | 726,428,651.51 | 362,752,486.50 | 529,778,056.02 | 276,767,844.08 |
| 其他业务(元) | - | - | - | 26,769,859.38 |
| 营业成本(元) | ||||
| 感染控制解决方案(元) | 379,130,392.91 | 197,981,649.38 | 525,348,102.85 | 266,279,826.19 |
| 呼吸治疗解决方案(元) | 1,479,342,181.48 | 1,054,783,951.83 | 1,044,153,514.34 | 580,976,650.62 |
| 急救(元) | 110,663,605.10 | 54,280,467.33 | 110,369,640.38 | 45,202,166.03 |
| 家用类电子检测及体外诊断(元) | 794,270,236.32 | 486,038,153.88 | 817,991,177.15 | 428,215,575.76 |
| 康复及临床器械(元) | 812,006,834.49 | 463,293,600.68 | 939,651,319.93 | 433,818,027.05 |
| 糖尿病护理解决方案(元) | 271,076,120.96 | 139,567,922.37 | 207,414,879.15 | 106,101,735.77 |
| 其他业务(元) | - | - | - | 13,946,453.66 |
| 毛利(元) | ||||
| 感染控制解决方案(元) | 376,998,805.37 | 226,273,561.79 | 658,862,830.67 | 360,766,565.21 |
| 呼吸治疗解决方案(元) | 1,891,901,674.30 | 1,253,541,508.85 | 1,195,108,064.87 | 518,286,299.39 |
| 急救(元) | 52,833,616.95 | 25,754,074.15 | 40,966,979.68 | 18,693,945.75 |
| 家用类电子检测及体外诊断(元) | 879,447,303.86 | 581,891,555.28 | 702,871,769.26 | 381,764,418.00 |
| 康复及临床器械(元) | 415,897,090.05 | 244,774,395.08 | 468,809,567.12 | 215,260,766.13 |
| 糖尿病护理解决方案(元) | 455,352,530.55 | 223,184,564.13 | 322,363,176.87 | 170,666,108.31 |
| 其他业务(元) | - | - | - | 12,823,405.72 |
| 毛利率(%) | ||||
| 感染控制解决方案(%) | 49.86 | 53.33 | 55.64 | 57.53 |
| 呼吸治疗解决方案(%) | 56.12 | 54.31 | 53.37 | 47.15 |
| 急救(%) | 32.31 | 32.18 | 27.07 | 29.26 |
| 家用类电子检测及体外诊断(%) | 52.54 | 54.49 | 46.22 | 47.13 |
| 康复及临床器械(%) | 33.87 | 34.57 | 33.29 | 33.16 |
| 糖尿病护理解决方案(%) | 62.68 | 61.53 | 60.85 | 61.66 |
| 其他业务(%) | - | - | - | 47.90 |
| 收入构成(%) | ||||
| 感染控制解决方案(%) | 9.55 | 8.57 | 16.84 | 17.65 |
| 呼吸治疗解决方案(%) | 42.57 | 46.62 | 31.84 | 30.94 |
| 急救(%) | 2.06 | 1.62 | 2.15 | 1.80 |
| 家用类电子检测及体外诊断(%) | 21.14 | 21.57 | 21.62 | 22.80 |
| 康复及临床器械(%) | 15.51 | 14.30 | 20.02 | 18.27 |
| 糖尿病护理解决方案(%) | 9.17 | 7.33 | 7.53 | 7.79 |
| 其他业务(%) | - | - | - | 0.75 |
| 毛利构成(%) | ||||
| 感染控制解决方案(%) | 9.26 | 8.85 | 19.44 | 21.50 |
| 呼吸治疗解决方案(%) | 46.46 | 49.05 | 35.26 | 30.88 |
| 急救(%) | 1.30 | 1.01 | 1.21 | 1.11 |
| 家用类电子检测及体外诊断(%) | 21.60 | 22.77 | 20.74 | 22.75 |
| 康复及临床器械(%) | 10.21 | 9.58 | 13.83 | 12.83 |
| 糖尿病护理解决方案(%) | 11.18 | 8.73 | 9.51 | 10.17 |
| 其他业务(%) | - | - | - | 0.76 |